Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAGM.L Regulatory News (AGM)

  • There is currently no data for AGM

Board & Operational Appointments

25 Jan 2017 07:00

RNS Number : 0174V
Applied Graphene Materials PLC
25 January 2017
 

 

 

 

 

25th January 2017

 

Applied Graphene Materials plc

("Applied Graphene Materials", "the Group" or "the Company")

 

Board and operational appointments

 

Applied Graphene Materials, the producer of specialty graphene materials, announces the appointment of Gareth Hywel Jones (aged 48) to the Board as Chief Financial Officer of the Company, with effect from April 2017. Gareth is a Chartered Accountant with over 25 years' financial experience.

 

Gareth joins from the Emco Wheaton Division of private equity owned Gardner Denver Inc., the global provider of industrial equipment, technologies and services, where he has been Finance Director since 2013. Prior to this he spent ten years in a number of roles at Syltone plc, including divisional Finance Director and Group Financial Controller. After its acquisition by Gardner Denver Inc. in 2004, Gareth became European Finance Director and then Divisional Director of the Blower Division. Before joining Syltone plc he was Finance Director of private equity backed start-up, Vireol Bio-Industries plc, which was seeking funding to design, construct and operate a bioethanol process facility. During his time with Vireol Bio-Industries, Gareth was responsible for securing equity investment and bank financing and played a key part in the acquisition of a new facility in the USA.

 

Gareth qualified as a Chartered Accountant with PricewaterhouseCoopers in 1993. 

 

Operational Appointments

The appointment of Gareth comes at a period of significant planned development for the Company with two key operational appointments in the UK:

 

· William Weaver, as Technical Director, who joins from Nuplex industries, where he led the advanced coating collaborations with a large range of multi-nationals.

 

· Helen Hatcher, as the new Global Coatings Director who joins from Sudarshan Europe, where she was Head of Sales Marketing and Operations. Helen helped establish their European organisation in 2007.

 

 

The Company is also pleased to announce that as part of its continued development within the American markets, Kevin Jackson joined the team in December 2016 as the new United States Business Development Manager. Kevin joins from Ribbon Technology Corp where he managed a team developing manufacturing and selling speciality chemicals/coatings into North and South America.

 

Jon Mabbitt, Chief Executive, commented:

 

"We are delighted to welcome Gareth to Applied Graphene Materials. His extensive experience in materials and manufacturing will be a huge asset to the Company as it moves into the next phase of development. Additionally, his international experience and understanding of the US market will be of significant benefit as we continue to broaden our international opportunities.

 

We are equally excited about the key operational appointments we have made in the recent months. These reflect the ambition, confidence and clear progress the Company is making in its target sectors and geographies."

 

ADDITIONAL INFORMATION

 

Other than as set out below, there is no further information to be disclosed under schedule 2(g) and Rule 17 of the AIM Rules in respect of Mr Jones' appointment.

 

Mr Jones is, or has been, a director of the following companies during the previous five years:

 

Current Directorships:

Previous Directorships:

Gardner Denver Group Services Limited

Vireol Bio-Industries plc

Vireol Limited

 

 

 

Ends

 

For further information, please contact:

 

Applied Graphene Materials +44 (0) 1642 438 214

Jon Mabbitt, Chief Executive Officer

 

N+1 Singer +44 (0) 207 496 3000

Richard Lindley / Nick Owen / James White

 

Hudson Sandler +44 (0) 207 796 4133

Charlie Jack / Emily Dillon / Jocelyn Spottiswoode

 

 

Notes to Editors

Applied Graphene Materials

Applied Graphene Materials was founded by Professor Karl Coleman in 2010 with its operations and processes based on technology that he initially developed at Durham University. The Group is based at the Wilton Site on Teesside and was admitted to AIM in November 2013.

 

Applied Graphene Materials has developed a proprietary bottom-up process which produces graphene nanoplatelets of consistently high purity using a continuous process. The Group deploys two patent protected manufacturing processes based on sustainable, readily available raw materials. These processes do not rely on the supply of graphite, unlike a number of other graphene production techniques. Applied Graphene Materials owns the intellectual property and know-how behind these processes.

 

Applied Graphene Materials works in partnership with its customers using its knowledge and expertise to provide bespoke graphene dispersions and formats to deliver enhancements and benefits for a wide range of applications.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDPGUMUGUPMGRC
Date   Source Headline
13th Dec 20217:00 amRNSAGM launches own range of anti-corrosion primers
7th Dec 202112:40 pmRNSAGM Statement
7th Dec 20217:00 amRNSAGM Receives Patent for Anti-corrosion Innovation
29th Nov 20217:00 amRNSAGM to Webcast at VirtualInvestorConferences.com
13th Oct 20217:00 amRNSFull year results for the year ended 31 July 2021
7th Oct 20217:00 amRNSInvestor Presentation
5th Oct 20213:49 pmRNSAGM joins the GEIC
27th Sep 20217:00 amRNSNotice of Preliminary Results
20th Sep 20217:00 amRNSFour further products launched by AGM customers
29th Jul 20217:05 amRNSAGM launches eco-friendly graphene dispersions
29th Jul 20217:00 amRNSAGM Commences Trading on OTCQX Best Market in USA
6th Jul 20217:00 amRNSAGM presents at major US coatings conferences
23rd Jun 20214:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20214:35 pmRNSPrice Monitoring Extension
20th May 20217:00 amRNSAGM joins Nanotechnology Industries Association
18th May 20217:00 amRNSCustomer launches graphene-based spray for bikes
5th May 20217:00 amRNSAGM to showcase new technology at industry events
30th Mar 20217:00 amRNSAGM customer launches two graphene-based sealants
24th Mar 20217:01 amRNSInterim Results
24th Mar 20217:00 amRNSDirectorate Change
23rd Mar 20217:00 amRNSAGM announces appointment of joint broker
15th Mar 20217:00 amRNSAGM present on technology for water-based coatings
9th Mar 20212:47 pmRNSHolding(s) in Company
9th Mar 20217:00 amRNSNotice of Interim Results
18th Feb 20218:00 amRNSHolding(s) in Company
15th Feb 20218:37 amRNSDirector/PDMR Shareholding
12th Feb 202111:28 amRNSResult of General Meeting, Issue of Equity and TVR
9th Feb 20215:21 pmRNSHolding(s) in Company
3rd Feb 20217:00 amRNSAGM customer launches new graphene enhanced wax
28th Jan 202112:26 pmRNSPosting of Shareholder Circular and Notice of GM
27th Jan 20219:05 amRNSSecond Price Monitoring Extn
27th Jan 20219:00 amRNSPrice Monitoring Extension
27th Jan 20218:22 amRNSResult of Fundraise
27th Jan 20217:00 amRNSClose of Accelerated Bookbuild & PrimaryBid Offer
26th Jan 20214:48 pmRNSProposed Placing to raise £5.5 million
26th Jan 20214:47 pmRNSPrimaryBid.com Offer
14th Jan 20219:06 amRNSSecond Price Monitoring Extn
14th Jan 20219:00 amRNSPrice Monitoring Extension
14th Jan 20217:00 amRNSEU regulator approves large volume use of graphene
18th Dec 20207:00 amRNSCustomer launches 2nd graphene-enhanced car wax
15th Dec 202011:47 amRNSResult of AGM
14th Dec 20207:00 amRNSAGM signs distribution agreement in South Korea
30th Nov 20204:40 pmRNSSecond Price Monitoring Extn
30th Nov 20204:36 pmRNSPrice Monitoring Extension
30th Oct 20204:41 pmRNSSecond Price Monitoring Extn
30th Oct 20204:36 pmRNSPrice Monitoring Extension
30th Oct 20207:00 amRNSAGM signs up distribution partner in Turkey
21st Oct 20206:18 pmRNSIssue of Equity, PDMR Dealing and TVR
15th Oct 20209:05 amRNSSecond Price Monitoring Extn
15th Oct 20209:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.